{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T11:18:55Z","timestamp":1721387935373},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T00:00:00Z","timestamp":1418774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biotechnol Lett"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s10529-014-1746-4","type":"journal-article","created":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T09:21:29Z","timestamp":1418721689000},"page":"779-785","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CXCL10\/XCL1 fusokine elicits in vitro and in vivo chemotaxis"],"prefix":"10.1007","volume":"37","author":[{"given":"Yessica E.","family":"Sanchez-Lugo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose J.","family":"Perez-Trujillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Gutierrez-Puente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aracely","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto","family":"Rodriguez-Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oralia","family":"Barboza-Quintana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo E.","family":"Mu\u00f1oz-Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odila","family":"Saucedo-Cardenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto Montes","family":"de Oca-Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J.","family":"Loera-Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,17]]},"reference":[{"key":"1746_CR1","first-page":"57","volume":"167","author":"CM Cairns","year":"2001","unstructured":"Cairns CM, Gordon JR, Li F et al (2001) Lymphotactin expression by engineered myeloma cells drives tumor regression: mediation by CD4+ and CD8+ T cells and neutrophils expressing XCR1 receptor. J Immunol Baltim Md 1950 167:57\u201365","journal-title":"J Immunol Baltim Md 1950"},{"key":"1746_CR2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1172\/JCI200112346","volume":"108","author":"W-F Cheng","year":"2001","unstructured":"Cheng W-F, Hung C-F, Chai C-Y et al (2001) Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest 108:669\u2013678","journal-title":"J Clin Invest"},{"key":"1746_CR3","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","volume":"168","author":"JH Dufour","year":"2002","unstructured":"Dufour JH, Dziejman M, Liu MT et al (2002) IFN-\u03b3-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 168:3195\u20133204. doi: 10.4049\/jimmunol.168.7.3195","journal-title":"J Immunol"},{"key":"1746_CR4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri1842","volume":"6","author":"L Gattinoni","year":"2006","unstructured":"Gattinoni L, Powell DJ, Rosenberg SA, Restifo NP (2006) Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 6:383\u2013393","journal-title":"Nat Rev Immunol"},{"key":"1746_CR5","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00262-006-0247-2","volume":"56","author":"JG Gomez-Gutierrez","year":"2007","unstructured":"Gomez-Gutierrez JG, Elpek KG, de Oca-Luna RM et al (2007) Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice. Cancer Immunol Immunother CII 56:997\u20131007","journal-title":"Cancer Immunol Immunother CII"},{"key":"1746_CR6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/bjc.2011.189","volume":"105","author":"MJM Gooden","year":"2011","unstructured":"Gooden MJM, de Bock GH, Leffers N et al (2011) The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer 105:93\u2013103","journal-title":"Br J Cancer"},{"key":"1746_CR7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/ijc.20043","volume":"109","author":"H Huang","year":"2004","unstructured":"Huang H, Xiang J (2004) Synergistic effect of lymphotactin and interferon gamma-inducible protein-10 transgene expression in T-cell localization and adoptive T-cell therapy of tumors. Int J Cancer J Int Cancer 109:817\u2013825","journal-title":"Int J Cancer J Int Cancer"},{"key":"1746_CR8","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/nprot.2012.085","volume":"7","author":"M K\u00e4llberg","year":"2012","unstructured":"K\u00e4llberg M, Wang H, Wang S et al (2012) Template-based protein structure modeling using the RaptorX web server. Nat Protoc 7:1511\u20131522","journal-title":"Nat Protoc"},{"key":"1746_CR9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.micinf.2011.10.003","volume":"14","author":"Y Lei","year":"2012","unstructured":"Lei Y, Takahama Y (2012) XCL1 and XCR1 in the immune system. Microbes Infect Inst Pasteur 14:262\u2013267","journal-title":"Microbes Infect Inst Pasteur"},{"key":"1746_CR10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nri722","volume":"2","author":"AEI Proudfoot","year":"2002","unstructured":"Proudfoot AEI (2002) Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2:106\u2013115","journal-title":"Nat Rev Immunol"},{"key":"1746_CR11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2007.05.013","volume":"256","author":"D Raman","year":"2007","unstructured":"Raman D, Baugher PJ, Thu YM, Richmond A (2007) Role of chemokines in tumor growth. Cancer Lett 256:137\u2013165","journal-title":"Cancer Lett"},{"key":"1746_CR12","first-page":"227","volume":"30","author":"HV Russell","year":"2007","unstructured":"Russell HV, Strother D, Mei Z et al (2007) Phase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactin. J Immunother Hagerstown Md 1997 30:227\u2013233","journal-title":"J Immunother Hagerstown Md 1997"},{"key":"1746_CR13","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00262-010-0901-6","volume":"59","author":"P Wang","year":"2010","unstructured":"Wang P, Yang X, Xu W et al (2010) Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapy. Cancer Immunol Immunother CII 59:1715\u20131726","journal-title":"Cancer Immunol Immunother CII"},{"key":"1746_CR14","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00262-013-1426-6","volume":"62","author":"X Wang","year":"2013","unstructured":"Wang X, Lu X-L, Zhao H-Y et al (2013) A novel recombinant protein of IP10-EGFRvIIIscFv and CD8(+) cytotoxic T lymphocytes synergistically inhibits the growth of implanted glioma in mice. Cancer Immunol Immunother CII 62:1261\u20131272","journal-title":"Cancer Immunol Immunother CII"},{"key":"1746_CR15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/lary.22133","volume":"122","author":"D Wansom","year":"2012","unstructured":"Wansom D, Light E, Thomas D et al (2012) Infiltrating lymphocytes and human papillomavirus-16 associated oropharynx cancer. Laryngoscope 122:121\u2013127","journal-title":"Laryngoscope"},{"key":"1746_CR16","author":"E Wennerberg","year":"2014","unstructured":"Wennerberg E, Kremer V, Childs R, Lundqvist A (2014) CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo. Cancer Immunol Immunother CII. doi: 10.1007\/s00262-014-1629-5","journal-title":"Cancer Immunol Immunother CII"},{"key":"1746_CR17","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.4049\/jimmunol.1003699","volume":"186","author":"P Williams","year":"2011","unstructured":"Williams P, Galipeau J (2011) GM-CSF\u2013based fusion Cytokines as ligands for immune modulation. J Immunol 186:5527\u20135532","journal-title":"J Immunol"},{"key":"1746_CR18","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1189\/jlb.0306212","volume":"80","author":"X Yang","year":"2006","unstructured":"Yang X, Chu Y, Wang Y et al (2006) Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity. J Leukoc Biol 80:1434\u20131444","journal-title":"J Leukoc Biol"},{"key":"1746_CR19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00262-010-0955-5","volume":"60","author":"J Zhang","year":"2011","unstructured":"Zhang J, Zhou Z, Wang C et al (2011) Reduced tumorigenesis of EG7 after interleukin-10 gene transfer and enhanced efficacy in combination with intratumorally injection of adenovirus-mediated lymphotactin and the underlying mechanism. Cancer Immunol Immunother CII 60:559\u2013573","journal-title":"Cancer Immunol Immunother CII"}],"container-title":["Biotechnology Letters"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-014-1746-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10529-014-1746-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-014-1746-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T20:05:12Z","timestamp":1559160312000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10529-014-1746-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,17]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["1746"],"URL":"https:\/\/doi.org\/10.1007\/s10529-014-1746-4","relation":{},"ISSN":["0141-5492","1573-6776"],"issn-type":[{"value":"0141-5492","type":"print"},{"value":"1573-6776","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,17]]}}}